$PCVX

$71.12▲ +9.4% YTD

11 SEC 13D/G filings tracked · Last updated Oct 10, 2026

Filing History

CP $71.12▲ +9.4%Oct 10, 2026 · ThinkSabio Blog

$PCVX - Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full…

News

PCVX ▼ -0.9% - Vaxcyte, Inc.

CP $66.08▲ -0.9%Oct 7, 2026 · ThinkSabio Blog

$PCVX Vaxcyte: Prices $500M Equity Offering at $64 per Share and $500M Convertible Notes Offering ? • Equity offering includes 7.41M shares plus pre-f…

News

PCVX ▼ -9.8% - Vaxcyte, Inc.

CP $66.70▲ -9.8%Oct 7, 2026 · ThinkSabio Blog

$PCVX - Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes…

News

PCVX ▲ +27.3% - Vaxcyte, Inc.

CP $71.84▲ +27.3%Oct 5, 2026 · ThinkSabio Blog

$PCVX - Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes…

News

PCVX ▲ +10.4% - Vaxcyte, Inc.

CP $62.32▲ +10.4%Oct 5, 2026 · ThinkSabio Blog

$PCVX - Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate V…

News

PCVX ▲ +0.7% - Vaxcyte, Inc.

CP $56.48▲ +0.7%Oct 4, 2026 · ThinkSabio Blog

$PCVX - Vaxcyte to Host Webcast and Conference Call to Present Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-V…

News

PCVX ▼ -1.9% - Vaxcyte, Inc.

CP $60.41▲ -1.9%Sep 3, 2026 · ThinkSabio Blog

$PCVX - Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data…

News

PCVX ▲ +0.1% - Vaxcyte, Inc.

CP $61.16▲ +0.1%Aug 27, 2026 · ThinkSabio Blog

$PCVX - Vaxcyte to Participate in Upcoming Investor Conferences…

SEC 13D/G

PCVX - Vaxcyte, Inc. - SEC Filing Update (11-AUG-2026) | ThinkSabio - Stocks Simplified

$59.04▲ 27.02%Aug 11, 2026 · ThinkSabio Blog

$PCVX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PCVX Vaxcyte, Inc. : $59.04 Sector: Healthcare | YTD: 🔼+ 27.02%…

SEC 13D/G

PCVX - Vaxcyte, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified

$57.68▲ 24.10%Aug 7, 2026 · ThinkSabio Blog

$PCVX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PCVX Vaxcyte, Inc. : $57.68 Sector: Healthcare | YTD: 🔼+ 24.10%…

SEC 13D/G

PCVX - Vaxcyte, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$57.92▲ 24.61%Aug 6, 2026 · ThinkSabio Blog

$PCVX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PCVX Vaxcyte, Inc. : $57.92 Sector: Healthcare | YTD: 🔼+ 24.61%…